Atypical Chronic Lymphocytic Leukemia—The Current Status

T Robak, A Krawczyńska, B Cebula-Obrzut… - Cancers, 2023 - mdpi.com
Simple Summary The degree of differentiation of leukemic cells seen in clinical practice is
significant. The dissimilarities concern morphology, cytogenetics, and immunophenotype …

Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders

N Güell, P Mozas, A Jimenez-Rueda… - Critical Reviews in …, 2023 - Taylor & Francis
The diagnosis of leukemic B-cell lymphoproliferative disorders (B-LPDs) is made by
integrating clinical, cytological, cytometric, cytogenetic, and molecular data. This leaves …

LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia

X Du, H Liu, C Yang, X Shi, L Cao, X Zhao, Y Miao… - Leukemia Research, 2021 - Elsevier
Chronic lymphocytic leukemia (CLL) is a malignant disorder of mature B lymphocytes, and
the precise pathogenesis is largely unknown at present. This study set out to screen the …

The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype

Y Aruga, C Ikeda, H Matsushita, S Makita… - Scientific Reports, 2024 - nature.com
In recent years, the significance of detecting minimal/measurable residual disease (MRD) in
chronic lymphocytic leukemia (CLL) has increased due to the availability of highly effective …

Assessment for acceleration and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma using histologic and immunohistochemical features: a …

ME Moore, NS Aguilera, I Obiorah, E Williams… - Journal of …, 2024 - Springer
Morphologic features of aggressive/“accelerated” chronic lymphocytic leukemia/small
lymphocytic lymphoma (aCLL/SLL) have been described. Richter transformation (RT) also …

Leukemic-phase mucosa-associated lymphoid tissue lymphoma

T Yotsuyanagi, N Tomita, Y Saiki, A Uchida… - International Journal of …, 2023 - Springer
A 78-year-old man presenting with leukocytosis was admitted to our hospital. The patient
was asymptomatic and showed no lymphadenopathy. Peripheral blood flow cytometry …

Updates in Immunohistochemistry for Hematopoietic and Lymphoid Neoplasms

H Kavus, Y Ding, M Dhesi - Archives of Pathology & …, 2024 - meridian.allenpress.com
Context.—In their 2014 article “New Immunohistochemistry for B-cell Lymphoma and
Hodgkin Lymphoma,” Zhang and Aguilera reviewed new immunohistochemical markers for …

淋巴样增强结合因子1 在B 细胞慢性淋巴增殖性疾病中的表达.

赵敏, 倪平, 翟惠莹, 靳小可… - Journal of Practical …, 2024 - search.ebscohost.com
目的研究淋巴样增强结合因子1 (lymphoid enhancer-binding factor 1, LEF1) 在B
细胞慢性淋巴增殖性疾病(B cell chronic lymphoproliferative disorders, B-CLPD) …

[PDF][PDF] Biologic characterization of atypical chronic lymphocytic leukaemia

DS Soliman, E Al‐Kuwari, R Al‐Abdulla, P Chandra… - 2021 - manara.qnl.qa
Biologic characterization of atypical chronic lymphocytic leukaemia Page 1 Biologic
characterization of atypical chronic lymphocytic leukaemia Dina S. Soliman, Einas Al‐Kuwari …

New biological insights into atypical chronic lymphocytic leukemia.

M Sorigue, J Junca, L Zamora - International Journal of …, 2022 - search.ebscohost.com
The article explores A 50-year-old lady was presented with a history of dysphagia, vomiting,
and bleeding tendency. With an outside CT scan suggesting narrowing in esophagus, the …